Considerations on what constitutes a 'qualified statistician' in regulatory guidelines

Area of Science:

• Biostatistics
• Clinical Trials
• Regulatory Science

Background:

• International regulatory guidelines mandate a 'qualified statistician' for clinical trial oversight.
• The statistical aspects of drug licensing trials require expert responsibility.
• A lack of consensus exists regarding the definition of a 'qualified statistician'.

Purpose of the Study:

• To address the ambiguity surrounding the definition of a 'qualified statistician'.
• To stimulate discussion on the qualifications and responsibilities of statisticians in clinical trials.
• To inform the development of consensus on statistical expertise in drug licensing.

Main Methods:

• This paper is a reflection piece, not an empirical study.
• It analyzes the current regulatory landscape and existing guidelines.
• It identifies the need for a defined standard for statistical qualification.

Main Results:

• There is no universally accepted definition for a 'qualified statistician'.
• This ambiguity poses challenges for ensuring adequate statistical oversight in drug licensing.
• The International Society for Clinical Biostatistics (ISCB) recognizes this gap.

Conclusions:

• A clear definition of a 'qualified statistician' is crucial for regulatory compliance.
• Further discussion and consensus-building are needed within the biostatistics community.
• Establishing standards will enhance the integrity and reliability of clinical trial data for drug approval.